✦ LIBER ✦

1051 – Lurasidone in the treatment of early-stage schizophrenia: a post-hoc analysis of three pooled acute treatment studies

✍ Scribed by Lieberman, J.A.; Pikalov, A.; Hsu, J.; Cucchiaro, J.; Werner, P.; Grossman, F.; Loebel, A.

Book ID: 122460270
Publisher: Elsevier Science
Year: 2013
Tongue: French
Weight: 43 KB
Volume: 28
Category: Article
ISSN: 0924-9338
DOI: 10.1016/S0924-9338(13)76171-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.d.051 Lurasidone in the treatment of

P.3.d.051 Lurasidone in the treatment of early-stage schizophrenia: a post-hoc analysis of three pooled acute treatment studies

✍ Lieberman, J.; Pikalov, A.; Hsu, J.; Cucchiaro, J.; Werner, P.; Grossman, F.; Lo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Poster #T187 EFFICACY OF LURASIDONE IN T

Poster #T187 EFFICACY OF LURASIDONE IN THE TREATMENT OF SCHIZOPHRENIA WITH PROMINENT NEGATIVE SYMPTOMS: A POST-HOC ANALYSIS OF SHORT-TERM TRIALS

✍ Pikalov, Andrei; Schooler, Nina; Hsu, Jay; Cucchiaro, Josephine; Goldman, Robert 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 92 KB

A post hoc analysis of transitioning to

A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia

✍ John Battaglia; John P. Houston; Jonna Ahl; Adam L. Meyers; Christopher J. Kaise 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 881 KB

Efficacy of iloperidone in the short-ter

Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials

✍ Leslie Citrome; Xiangyi Meng; Marla Hochfeld; Stephen M Stahl 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB 👁 2 views

## Objectives The efficacy and tolerability characteristics of an antipsychotic are difficult to determine from a single registration study. We thus conducted an analysis that assessed key efficacy and tolerability outcomes __post hoc__ from four pooled short‐term (4–6 weeks) phase III studies that

PReS-FINAL-2157: Efficacy of canakinumab

PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis

✍ Quartier, P; Brunner, H; Constantin, T; Padeh, S; Calvo, I; Erguven, M; Goffin, 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 108 KB

P03-242 - Efficacy and tolerability of q

P03-242 - Efficacy and tolerability of quetiapine XR 400/600/800mg/day in acute schizophrenia: a post-hoc analysis of data from two pooled randomised studies

✍ Kahn, R.; Kalali, A.; Gustafsson, U.; Nyberg, S. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 French ⚖ 12 KB